Chemoinformaics analysis of 2-[(E)-3-(3,4-DIHYDROXYPHENYL)PROP-2-ENOYL]OXY-3-HYDROXYBUTANEDIOIC ACID
| Molecular Weight | 312.23 | nRot | 6 |
| Heavy Atom Molecular Weight | 300.134 | nRig | 32 |
| Exact Molecular Weight | 312.048 | nRing | 1 |
| Solubility: LogS | -2.609 | nHRing | 0 |
| Solubility: LogP | 0.099 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 1 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 6 |
| nHA | 7 | APOL | 36.9295 |
| nHD | 5 | BPOL | 16.3785 |
| QED | 0.24 |
| Synth | 5.446 |
| Natural Product Likeliness | 2.713 |
| NR-PPAR-gamma | 0.935 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.17 |
| HIA | 0.95 |
| CACO-2 | -5.92 |
| MDCK | 0.0000226 |
| BBB | 0.955 |
| PPB | 0.727225 |
| VDSS | 0.827 |
| FU | 0.117611 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.79 |
| CYP2c19-inh | 0.004 |
| CYP2c19-sub | 0.285 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.222 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.119 |
| CYP3a4-inh | 0.172 |
| CYP3a4-sub | 0.116 |
| CL | 4.793 |
| T12 | 0.074 |
| hERG | 0.119 |
| Ames | 0.108 |
| ROA | 0.991 |
| SkinSen | 0.071 |
| Carcinogencity | 0.577 |
| EI | 0.005 |
| Respiratory | 0.863 |
| NR-Aromatase | 0.891 |
| Antiviral | Yes |
| Prediction | 0.53878 |